Search

Your search keyword '"Muthumani, P."' showing total 171 results

Search Constraints

Start Over You searched for: Author "Muthumani, P." Remove constraint Author: "Muthumani, P."
171 results on '"Muthumani, P."'

Search Results

1. Pretreatment with IL-15 and IL-18 rescues natural killer cells from granzyme B-mediated apoptosis after cryopreservation.

5. An overview of SARS-CoV-2 viral proteins with relevance to improved diagnostic and therapeutic platforms

9. Pretreatment with IL-15 and IL-18 rescues natural killer cells from granzyme B-mediated apoptosis after cryopreservation

11. Knowledge and attitude on childhood cancer survivorship among healthcare trainees: a multicentre study from India

13. Safety and immunogenicity of the bi-cistronic GLS-5310 COVID-19 DNA vaccine delivered with the GeneDerm suction device

14. Tumor-infiltrating mast cells are associated with resistance to anti-PD-1 therapy.

15. Characterization of a small molecule modulator of inflammatory cytokine production

17. Siglec-9 Restrains Antibody-Dependent Natural Killer Cell Cytotoxicity against SARS-CoV-2

18. Predicting Strength Properties of High-Performance Concrete Modified with Natural Aggregates and Ferroslag under Varied Curing Conditions

19. Elicitation of immune responses against Nipah virus by an engineered synthetic DNA vaccine

20. Expanding the Reach of Monoclonal Antibodies: A Review of Synthetic Nucleic Acid Delivery in Immunotherapy

21. Preexisting vs. de novo antibodies against SARS-CoV-2 in individuals without or with virus infection: impact on antibody therapy, vaccine research and serological testing

22. Cross-reactive antibodies facilitate innate sensing of dengue and Zika viruses

23. DNA Vaccines for Epidemic Preparedness: SARS-CoV-2 and Beyond

24. Tumor-infiltrating mast cells are associated with resistance to anti-PD-1 therapy

25. Immune Responses of a Novel Bi-Cistronic SARS-CoV-2 DNA Vaccine Following Intradermal Immunization With Suction Delivery

27. Active immunoprophylaxis with a synthetic DNA-encoded monoclonal anti-respiratory syncytial virus scFv-Fc fusion protein confers protection against infection and durable activity

28. Neutralization of hepatitis B virus by a novel DNA-encoded monoclonal antibody

29. Synthetic DNA Delivery of an Engineered Arginase Enzyme Can Modulate Specific Immunity In Vivo

30. Immunogenicity of a DNA vaccine candidate for COVID-19

31. Synthetic nucleic acid antibody prophylaxis confers rapid and durable protective immunity against Zika virus challenge

34. Siglec-9 defines and restrains a natural killer subpopulation highly cytotoxic to HIV-infected cells

35. Development of Siglec-9 Blocking Antibody to Enhance Anti-Tumor Immunity

36. Intradermal-delivered DNA vaccine induces durable immunity mediating a reduction in viral load in a rhesus macaque SARS-CoV-2 challenge model

37. A novel mouse AAV6 hACE2 transduction model of wild-type SARS-CoV-2 infection studied using synDNA immunogens

38. Intradermal delivery of a synthetic DNA vaccine protects macaques from Middle East respiratory syndrome coronavirus

39. Landscape of humoral immune responses against SARS-CoV-2 in patients with COVID-19 disease and the value of antibody testing

41. A novel synthetic DNA vaccine elicits protective immune responses against Powassan virus.

42. In Vivo Assembly of Nanoparticles Achieved through Synergy of Structure‐Based Protein Engineering and Synthetic DNA Generates Enhanced Adaptive Immunity

43. Synthesis of indole–cycloalkyl[b]pyridine hybrids via a four-component six-step tandem process

44. Synthetic DNA delivery by electroporation promotes robust in vivo sulfation of broadly neutralizing anti-HIV immunoadhesin eCD4-IgResearch in context

45. Superfast Synthesis of Stabilized Silver Nanoparticles Using Aqueous Allium sativum (Garlic) Extract and Isoniazid Hydrazide Conjugates: Molecular Docking and In-Vitro Characterizations

46. Corrosion of metals exposed to 25% magnesium chloride solution and tensile stress: Field and laboratory studies

47. Immunogenicity of a DNA vaccine candidate for COVID-19

50. An engineered bispecific DNA-encoded IgG antibody protects against Pseudomonas aeruginosa in a pneumonia challenge model

Catalog

Books, media, physical & digital resources